Selective Mitochondrial Respiratory Complex I Subunit Deficiency Causes Tumor Immunogenicity
Liang, J.; Vitale, T.; Zhang, X.; Jackson, T. D.; Yu, D.; Jedrychowsk, M.; Gygi, S. P.; Widlund, H. R.; Wucherpfennig, K.; Puigserver, P.
Show abstract
Targeting of specific metabolic pathways in tumor cells has the potential to sensitize them to immune-mediated attack. Here we provide evidence for a specific means of mitochondrial respiratory Complex I (CI) inhibition that improves tumor immunogenicity and sensitivity to immune checkpoint blockade (ICB). Targeted genetic deletion of the CI subunits Ndufs4 and Ndufs6, but not other subunits, induces an immune-dependent tumor growth attenuation in mouse melanoma models. We show that deletion of Ndufs4 induces expression of the transcription factor Nlrc5 and genes in the MHC class I antigen presentation and processing pathway. This induction of MHC-related genes is driven by an accumulation of pyruvate dehydrogenase-dependent mitochondrial acetyl-CoA downstream of CI subunit deletion. This work provides a novel functional modality by which selective CI inhibition restricts tumor growth, suggesting that specific targeting of Ndufs4, or related CI subunits, increases T-cell mediated immunity and sensitivity to ICB.
Matching journals
The top 4 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- SMARCA4 deficient tumours are vulnerable to KDM6A/UTX and KDM6B/JMJD3 blockade 98%
- Depletion of nuclear pore protein NUP210 suppresses metastasis through heterochromatin-mediated disruption of tumor cell mechanical response 98%
- ANP32E drives vulnerability to ATR inhibitors by inducing R-loops-dependent Transcription Replication Conflicts in Triple Negative Breast Cancer 98%
Similar papers in this journal
- Extracellular 2’3’-cGAMP is an immunotransmitter produced by cancer cells and regulated by ENPP1 98%
- The neuroendocrine transition in prostate cancer is dynamic and dependent on ASCL1 98%
- Spatial proteomic characterization of HER2-positive breast tumors through neoadjuvant therapy predicts response 98%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.